Amlodipine Besylate/Bisoprolol Fumarate

苯磺酸氨氯地平/富马酸比索洛尔

Report date: 2023/02/09 14:15:16

Base Information

Drug NameAmlodipine Besylate/Bisoprolol Fumarate
Drug Alias NameAmlodipine Besylate and Bisoprolol Fumarate富马酸比索洛尔/苯磺酸氨氯地平Amlodipine/BisoprololBisoprolol Fumarate and Amlodipine BesylateConcor AM
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersBeta-1 adrenergic receptor antagonists
TargetsVoltage-gated calcium channelBeta-1 adrenergic receptor
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsEssential HypertensionHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryIndia
Original Approved Date2010/06/01
Country/TerritoryIndiaEUMainland China
CombinationsYes Amlodipine BesylateBisoprolol Fumarate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck
China Registration ClassN/A

Develop Information

Active CompaniesMerck KftMerck & Co Inc
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC07FB07
Related LinksN/A